Molecular mechanisms of cytoskeletal dysregulations in Spinal Muscular Atrophy (SMA)
- Alternative title
-
Molekulare Mechanismen der Dysregulation des Zytoskeletts in der Spinalen Muskelatrophie (SMA)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Event
-
Veröffentlichung
- (where)
-
Hannover
- (who)
-
Stiftung Tierärztliche Hochschule Hannover
- (when)
-
2023
- Creator
- Contributor
- URN
-
urn:nbn:de:gbv:95-119041
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schüning, Tobias
- Claus, Peter
- Ponimaskin, Evgeni
- Tipold, Andrea
- Stiftung Tierärztliche Hochschule Hannover
Time of origin
- 2023
Other Objects (12)
Cytoskeletal dysregulation in the motoneuron disease Spinal Muscular Atrophy (SMA)
Spinal muscular atrophy
Development of antisense oligonucleotide combinatorial therapies for spinal muscular atrophy (SMA)
Systematic Literature Review to Assess Economic Evaluations in Spinal Muscular Atrophy (SMA)
Treatment preference among patients with spinal muscular atrophy (SMA): a discrete choice experiment
Very severe spinal muscular atrophy (Type 0)
Correction to: Systematic Literature Review to Assess Economic Evaluations in Spinal Muscular Atrophy (SMA)
Dynamics and regulation of the actin cytoskeleton in the motoneuron disease Spinal Muscular Atrophy (SMA)
Actin-binding proteins in Spinal Muscular Atrophy (SMA) and other neurodegenerative diseases : Molecular disease mechanisms
Routine cerebrospinal fluid (CSF) parameters in patients with spinal muscular atrophy (SMA) treated with nusinersen
Disease burden of spinal muscular atrophy in Germany
Choosing Life with Spinal Muscular Atrophy Type 1
Cytoskeletal dysregulation in the motoneuron disease Spinal Muscular Atrophy (SMA)
Spinal muscular atrophy
Development of antisense oligonucleotide combinatorial therapies for spinal muscular atrophy (SMA)
Systematic Literature Review to Assess Economic Evaluations in Spinal Muscular Atrophy (SMA)
Treatment preference among patients with spinal muscular atrophy (SMA): a discrete choice experiment
Very severe spinal muscular atrophy (Type 0)
Correction to: Systematic Literature Review to Assess Economic Evaluations in Spinal Muscular Atrophy (SMA)
Dynamics and regulation of the actin cytoskeleton in the motoneuron disease Spinal Muscular Atrophy (SMA)
Actin-binding proteins in Spinal Muscular Atrophy (SMA) and other neurodegenerative diseases : Molecular disease mechanisms
Routine cerebrospinal fluid (CSF) parameters in patients with spinal muscular atrophy (SMA) treated with nusinersen
Disease burden of spinal muscular atrophy in Germany
Choosing Life with Spinal Muscular Atrophy Type 1
Cytoskeletal dysregulation in the motoneuron disease Spinal Muscular Atrophy (SMA)
Spinal muscular atrophy
Development of antisense oligonucleotide combinatorial therapies for spinal muscular atrophy (SMA)
Systematic Literature Review to Assess Economic Evaluations in Spinal Muscular Atrophy (SMA)
Treatment preference among patients with spinal muscular atrophy (SMA): a discrete choice experiment
Very severe spinal muscular atrophy (Type 0)
Correction to: Systematic Literature Review to Assess Economic Evaluations in Spinal Muscular Atrophy (SMA)
Dynamics and regulation of the actin cytoskeleton in the motoneuron disease Spinal Muscular Atrophy (SMA)
Actin-binding proteins in Spinal Muscular Atrophy (SMA) and other neurodegenerative diseases : Molecular disease mechanisms
Routine cerebrospinal fluid (CSF) parameters in patients with spinal muscular atrophy (SMA) treated with nusinersen
Disease burden of spinal muscular atrophy in Germany